DeNovaMed Inc.

Private

HalifaxHealthcare & Life Scienceshttps://denovamed.com/

Last Round

Seed

Aug 8, 2012

Total Funding Raised

$1.5M

Company Overview

DeNovaMed Inc. is a biotechnology company that develops novel antibiotic therapies to combat drug-resistant bacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antibiotic discoverydrug-resistant bacteriasuperbugscomputer-aided drug designCADDsmall-molecule antibioticsdiabetic foot ulcerspreclinical developmentinvestigational new drugINDmicropharmabiotech startupbacterial lipid metabolismACP synthase

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeNovaMed Inc. Comparables

Compare DeNovaMed Inc. with similar companies based on industry and business-model similarity.

DeNovaMed Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Sequella, Inc.	80%
Deinove	78%
Microbion Corporation	77%

View all Comparables

DeNovaMed Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Aug 8, 2012
Grant	Apr 1, 2012

View all Funding Rounds

Key People

Founding team and executive leadership

Christopher McMaster

President and CEO

Executive Team

DeNovaMed Inc. Investors

Notable investors and investment history

DeNovaMed Inc. investors
Investor	Rounds
Canadian Institutes of Health Research	Grant
Innovacorp	Seed
Canada Foundation for Innovation	Grant
National Research Council of Canada	Grant

View all Investors

DeNovaMed Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

DeNovaMed Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DeNovaMed Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHalifax

Employee Range5

Year Founded2006

Last FundingAug 8, 2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.